James Archetto, Vice President at Gaumard Scientific, designers and manufacturers of state-of-the-art, robot-like, patient simulators, discusses the advantages of simulation-based training and how it is improving COVID-19 readiness along with helping clinicians to develop the skills to use a ventilator.  The simulators are incredibly life-like and engage the emotions of the learner.

Jim Archetto, Vice President Gaumard Scientific describes the range of simulators available to train healthcare professionals in routine medical procedures as well as rarely seen scenarios.  Simulation becomes vital in the education process during these days of COVID-19. Life-like patient simulators are being used to train physicians and nurses to insert an IV, deliver babies, […]

Athersys has developed its MultiStem cell therapy for COVID-19 Acute respiratory distress syndrome (ARDS). Athersys CEO Gil Van Bokkelen, PhD, and CFO Ivor Macleod, recently spoke to Contagion providing background on the company and their MultiStem therapy.